Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004616 |
---|---|
Receipt number | R000005493 |
Scientific Title | A randomized phase ll study comparing neoadjuvant FAP and DCF for the resectable advanced esophageal cancer (OGSG 1003) |
Date of disclosure of the study information | 2010/12/01 |
Last modified on | 2020/01/05 17:29:33 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/11/24 19:24:03 | ||
2 | Update | 2011/03/02 17:40:03 | Key inclusion criteria Key inclusion criteria |
|
3 | Update | 2011/11/22 19:00:27 | Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2011/11/22 19:14:16 | Anticipated trial start date Last follow-up date |
|
5 | Update | 2012/06/24 22:58:02 | Public title Public title Acronym Acronym |
|
6 | Update | 2012/06/24 23:01:38 | Organization Organization Division name Division name Address Address TEL Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Organization1 Email1 |
|
7 | Update | 2012/12/25 22:07:32 | Recruitment status |
|
8 | Update | 2013/05/24 21:34:31 | Anticipated trial start date Last follow-up date |
|
9 | Update | 2014/07/27 22:45:24 | Date analysis concluded |
|
10 | Update | 2015/05/28 22:40:32 | Last follow-up date Publication of results Results Results |
|
11 | Update | 2015/05/28 22:50:56 | Email Institutions |
|
12 | Update | 2015/05/28 23:05:12 | Results Results |
|
13 | Update | 2015/05/28 23:18:00 | Institutions |
|
14 | Update | 2016/10/23 19:30:32 | Organization Name of primary person or sponsor Organization |
|
15 | Update | 2016/12/01 12:49:37 | Interventions/Control_1 Key inclusion criteria |
|
16 | Update | 2017/12/10 21:52:07 | Recruitment status Publication of results URL related to results and publications Results Results |
|
17 | Update | 2018/04/30 23:18:46 | Email |
|
18 | Update | 2018/04/30 23:23:11 | Results Results |
|
19 | Update | 2018/05/10 20:25:36 | Email |
|
20 | Update | 2020/01/05 14:29:25 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
21 | Update | 2020/01/05 17:29:33 | Results Results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Outcome measures Outcome measures |